KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 5,900.00
+200.00 (3.51%)
At close: Jan 28, 2026
KoBioLabs Company Description
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.
KoBioLabs, Inc
| Country | South Korea |
| Founded | 2014 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | GwangPyo Ko |
Contact Details
Address: 1 Gwanak-ro Seoul, 08826 South Korea | |
| Phone | 82 2 888 9964 |
| Website | kobiolabs.com |
Stock Details
| Ticker Symbol | 348150 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| GwangPyo Ko | Chief Executive Officer |
| Hyunkyu Lim | Chief Financial Officer |
| Han Seung Lee | Chief Operating Officer |